SNWV
SANUWAVE Health Inc
$
39.760
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
41.680
Open
37.940
VWAP
39.29
Vol
85.33K
Mkt Cap
340.66M
Low
37.500
Amount
3.35M
EV/EBITDA(TTM)
37.02
Total Shares
8.57M
EV
312.50M
EV/OCF(TTM)
208.47
P/S(TTM)
6.42
Sanuwave Health, Inc. is an ultrasound and shock wave technology company. It is a provider of wound care products. It is focused on the research, development, and commercialization of its patented, non-invasive, and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. It applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, and aesthetic/cosmetic. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression technology to converge at precise selected targets to produce short duration compression burst and are used in both wound and orthopedic applications under the brand names dermaPACE and others.
Show More
Valuation Metrics
The current forward P/E ratio for SANUWAVE Health Inc (SNWV.O) is 110.44, compared to its 5-year average forward P/E of 10.96. For a more detailed relative valuation and DCF analysis to assess SANUWAVE Health Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
10.96
Current PE
110.44
Overvalued PE
48.36
Undervalued PE
-26.43
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
3.13
Current EV/EBITDA
20.07
Overvalued EV/EBITDA
10.71
Undervalued EV/EBITDA
-4.44
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
0.93
Current PS
5.96
Overvalued PS
3.18
Undervalued PS
-1.32
Financials
Annual
Quarterly
FY2025Q2
YoY :
+41.92%
10.16M
Total Revenue
FY2025Q2
YoY :
-6.22%
1.87M
Operating Profit
FY2025Q2
YoY :
-100.00%
N/A
Net Income after Tax
FY2025Q2
YoY :
-99.44%
0.01
EPS - Diluted
FY2025Q2
YoY :
-78.16%
-166.00K
Free Cash Flow
FY2025Q2
YoY :
+8.28%
76.50
Gross Profit Margin - %
FY2025Q2
-0.27
FCF Margin - %
FY2025Q2
YoY :
-100.00%
N/A
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
SNWV News & Events
Events Timeline
2025-06-03 (ET)
2025-06-03
07:36:27
Sanuwave Health hires Dustin Libby as EVP of commercial operations
2025-05-28 (ET)
2025-05-28
16:35:22
Sanuwave Health to be included in Russell 2000 Index
2025-04-08 (ET)
2025-04-08
08:34:34
Sanuwave Health reports preliminary Q1 revenue $9.1M-$9.3M
Sign Up For More Events
Sign Up For More Events
News
3.0
07-14NewsfilterSanuwave Health Announces Preliminary Revenue Results for the Second Quarter 2025 (Ended June 30, 2025)
5.0
06-10NASDAQ.COMInsider Sale: Chief Operating Officer of $SNWV Sells 1,862 Shares
5.0
06-03NewsfilterSanuwave Health Appoints Industry Veteran Dustin Libby as Executive Vice President of Commercial Operations
Sign Up For More News
People Also Watch
AAPL
Apple Inc
229.350
USD
+4.24%
META
Meta Platforms Inc
769.300
USD
+0.98%
NVDA
NVIDIA Corp
182.700
USD
+1.07%
MSFT
Microsoft Corp
522.040
USD
+0.23%
AMZN
Amazon.com Inc
222.690
USD
-0.20%
TSLA
Tesla Inc
329.650
USD
+2.29%
WMT
Walmart Inc
103.730
USD
+0.59%
XOM
Exxon Mobil Corp
106.800
USD
+0.80%
ORCL
Oracle Corp
250.050
USD
+0.26%
AVGO
Broadcom Inc
304.970
USD
+0.40%
FAQ
What is SANUWAVE Health Inc (SNWV) stock price today?
The current price of SNWV is 39.76 USD — it has increased 15.85 % in the last trading day.
What is SANUWAVE Health Inc (SNWV)'s business?
What is the price predicton of SNWV Stock?
What is SANUWAVE Health Inc (SNWV)'s revenue for the last quarter?
What is SANUWAVE Health Inc (SNWV)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for SANUWAVE Health Inc (SNWV)'s fundamentals?
How many employees does SANUWAVE Health Inc (SNWV). have?